SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008668
Filing Date
2017-08-08
Accepted
2017-08-08 16:31:10
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 289911
2 ex31-1.htm EX-31.1 12445
3 ex31-2.htm EX-31.2 11840
4 ex32-1.htm EX-32.1 9737
  Complete submission text file 0001493152-17-008668.txt   2065324

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cocp-20170630.xml EX-101.INS 331965
6 XBRL SCHEMA FILE cocp-20170630.xsd EX-101.SCH 31558
7 XBRL CALCULATION FILE cocp-20170630_cal.xml EX-101.CAL 36405
8 XBRL DEFINITION FILE cocp-20170630_def.xml EX-101.DEF 95507
9 XBRL LABEL FILE cocp-20170630_lab.xml EX-101.LAB 199616
10 XBRL PRESENTATION FILE cocp-20170630_pre.xml EX-101.PRE 155881
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55158 | Film No.: 171015233
SIC: 2834 Pharmaceutical Preparations